SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Carl R. who wrote (2104)1/30/2000 10:23:00 AM
From: out_of_the_loop   of 5582
 
Well, we will just have to look at the patent when it comes out. In this case, without reading the patent itself, the method. In my opinion, includes the formulation AND the location for delivery - the title of the patent application "method of delivering zinc ions in a nasal gel to the nasal membrane to relieve symptoms of the common cold" (http://biz.yahoo.com/prnews/000112/az_gel_tec_1.html) seems to support my assertion. In any case, thanks for the comment - I am sure when it comes out, many will scrutinize the patent.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext